Identification of the prosurvival activity of nerve growth factor on cardiac myocytes

Cell Death and Differentiation

Volumn 15, Issue 2, 2008, Pages 299-311

  Caporali, A ^a   Sala Newby, G B ^a   Meloni, M ^a   Graiani, G ^b   Pani, E ^a   Cristofaro, B ^a   Newby, A C ^a   Madeddu, P ^a   Emanueli, C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOVIRUS VECTOR; ANGIOTENSIN II; NERVE GROWTH FACTOR; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE B; SERINE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TROPOMYOSIN TRKA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE TRANSFER; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; RAT; REOXYGENATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CARBAZOLES; CELL SURVIVAL; CELLS, CULTURED; CHROMONES; ENZYME INHIBITORS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INDOLE ALKALOIDS; MORPHOLINES; MYOCYTES, CARDIAC; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PC12 CELLS; PHOSPHORYLATION; RATS; RECEPTOR, TRKA; SIGNAL TRANSDUCTION; TRANSFECTION;

ADENOVIRIDAE; RATTUS;

EID: 38049134474     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402263     Document Type: Article

References (33)

1. Levi-Montalcini R. The nerve growth factor: Thirty-five years later. EMBO J 1987; 6: 1145-1154.
2. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci (Lond) 2006; 110: 167-173.
3. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002; 106: 2257-2262.
4. Cantarella G, Lempeur L, Presta M, Ribatti D, Lombardo G, Lazarovici P et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 2002; 16: 1307-1309.
5. Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C. Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 2004; 47: 1055-1063.
6. Graiani G, Emanueli C, Desortes E, Van Linthout S, Pinna A, Figueroa CD et al. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice, Diabetologia 2004; 47: 1047-1054.
7. Kermani P, Rath D, Jin DK, Whitlock P, Schaffer W, Chiang A et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 2004; 115: 653-663.
8. Kaye DM, Vaddadi G, Gruskin SIL, Du XL, Esler MD. Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res 2000; 86: 80-84.
9. Iade M. Fukuda K, Hisaka Y, Kimura K, Kawaguchi H, Fujita J et al. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest 2004; 113: 876-884.
10. Hiltunen JO, Laurikainen A, Väkevä A, Meri S, Saarma M. Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. J Pathol 2001; 194: 247-253.
11. Scarisbrick IA, Jones EG, Isackson PJ, Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. J Neurosience 1993; 13: 875-893.
12. Gan L, Zheng W, Chabot JG, Unterman TG, Quiron R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J Neurochem 2005; 93: 1209-1219.
13. Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003; 162: 613-622.
14. Vogt PK, Jiang H, Aoki M. Triple layer control: Phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005, 4: 908-913.
15. Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer, J Biol Chem 2002; 277: 47928-47937.
16. Sunters A, de Mattos SF, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA et al. FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 2003; 278: 49795-49805.
17. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M et al The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling, J Biol Chem 2005; 280: 20814-22023.
18. Morris JB, Kenney B, Huynh H, Woodcock EA, Regulation of the proapoptolic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists, Endocrinology 2005; 146: 4370-4376.
19. Yin H. Chao L, Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. J Biol Chem 2005: 280 8022-8030.
20. Goldenberg I, Grossman E, Jacobson KA, Shneyvays VV, Shainberg A: Angiotensin II-induced apoptosis in rat cardiomyocyte culture: A possible role of AT1 and AT2 receptors. J Hypertension 2001; 19 1681-1689.
21. Ross AH, McKinnon CA, Daou MC, Ratliff K, Wolf DE. Differential biological effects of K252a kinase inhibitors are related to membrane solubility but not permeability. J Neurochem 1995; 65: 2748-2756.
22. Thomberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281: 1312-1316. Review:
23. Kajstura J, Cigola E, Malhotra A. Li P. Cheng W, Meggs LG et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997, 29: 859-870.
24. Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 2000: 87: 118-125.
25. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E et al Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996; 28: 2005-2016.
26. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM. Apoptosis in human acute myocardial infarction. Circulation 1997; 95: 320-323.
27. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997; 80: 15-25.
28. Takemura G, Fujiwara H. Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 2004; 104: 1-16.
29. Ahn J-Y, Liu X, Liu Z, Pereira L, Cheng D, Pang J et al. Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 2006; 25: 2083-2095.
30. Catalucci D, Condorelli GL. Effects of Akt on cardiac myocytes: Location counts. Circ Res 2006; 99: 339-341.
31. Sala-Newby G. Freeman NVE, Curto MA. Newby AC. Metabolic and functional consequences of cytosolic 5-nucleotidase-IA overexpression in neonatal rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2003; 285 991-998.
32. Graiani G, Lagrasta C, Migliaccio E, Spillmann F, Meloni M, Madeddu P et al. Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 2005; 46 433-440.
33. Spillmann F, Graiani G, Van Lintout S, Maloni M, Campesi I, Lagrasta C et al. Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium. Regenerative Med 2006; 1: 235-254.